These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 36586393)
21. Impaired Phagocytosis in Dendritic Cells From Pediatric Patients With Type 1 Diabetes Does Not Hamper Their Tolerogenic Potential. Rodriguez-Fernandez S; Murillo M; Villalba A; Perna-Barrull D; Cano-Sarabia M; Gomez-Muñoz L; Aguilera E; Maspoch D; Vazquez F; Bel J; Vives-Pi M Front Immunol; 2019; 10():2811. PubMed ID: 31849983 [TBL] [Abstract][Full Text] [Related]
22. A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens. Almenara-Fuentes L; Rodriguez-Fernandez S; Rosell-Mases E; Kachler K; You A; Salvado M; Andreev D; Steffen U; Bang H; Bozec A; Schett G; Le Panse R; Verdaguer J; Dalmases M; Rodriguez-Vidal S; Barneda-Zahonero B; Vives-Pi M Nanomedicine; 2023 Feb; 48():102635. PubMed ID: 36481472 [TBL] [Abstract][Full Text] [Related]
23. The role of phosphatidylserine recognition receptors in multiple biological functions. Naeini MB; Bianconi V; Pirro M; Sahebkar A Cell Mol Biol Lett; 2020; 25():23. PubMed ID: 32226456 [TBL] [Abstract][Full Text] [Related]
24. Programmed cell clearance: From nematodes to humans. Klöditz K; Chen YZ; Xue D; Fadeel B Biochem Biophys Res Commun; 2017 Jan; 482(3):491-497. PubMed ID: 27919685 [TBL] [Abstract][Full Text] [Related]
26. Oral tolerance for treating uveitis - new hope for an old immunological mechanism. Thurau SR; Wildner G Prog Retin Eye Res; 2002 Nov; 21(6):577-89. PubMed ID: 12433378 [TBL] [Abstract][Full Text] [Related]
27. The central role of phosphatidylserine in the phagocytosis of apoptotic thymocytes. Schlegel RA; Callahan MK; Williamson P Ann N Y Acad Sci; 2000; 926():217-25. PubMed ID: 11193037 [TBL] [Abstract][Full Text] [Related]
28. Ebola Virus Requires Phosphatidylserine Scrambling Activity for Efficient Budding and Optimal Infectivity. Acciani MD; Lay Mendoza MF; Havranek KE; Duncan AM; Iyer H; Linn OL; Brindley MA J Virol; 2021 Sep; 95(20):e0116521. PubMed ID: 34319156 [TBL] [Abstract][Full Text] [Related]
29. Tolerogenic Lipid Nanoparticles for Delivering Self-Antigen mRNA for the Treatment of Experimental Autoimmune Encephalomyelitis. Gomi M; Nakayama Y; Sakurai Y; Oyama R; Iwasaki K; Doi M; Liu Y; Hori M; Watanabe H; Hashimoto K; Tanaka H; Tange K; Nakai Y; Akita H Pharmaceuticals (Basel); 2023 Sep; 16(9):. PubMed ID: 37765078 [TBL] [Abstract][Full Text] [Related]
30. Necrotic Cells Actively Attract Phagocytes through the Collaborative Action of Two Distinct PS-Exposure Mechanisms. Li Z; Venegas V; Nagaoka Y; Morino E; Raghavan P; Audhya A; Nakanishi Y; Zhou Z PLoS Genet; 2015 Jun; 11(6):e1005285. PubMed ID: 26061275 [TBL] [Abstract][Full Text] [Related]
31. Annexin-V promotes anti-tumor immunity and inhibits neuroblastoma growth in vivo. Yan X; Doffek K; Yin C; Krein M; Phillips M; Sugg SL; Johnson B; Shilyansky J Cancer Immunol Immunother; 2012 Nov; 61(11):1917-27. PubMed ID: 22476407 [TBL] [Abstract][Full Text] [Related]
33. CED-1, CED-7, and TTR-52 regulate surface phosphatidylserine expression on apoptotic and phagocytic cells. Mapes J; Chen YZ; Kim A; Mitani S; Kang BH; Xue D Curr Biol; 2012 Jul; 22(14):1267-75. PubMed ID: 22727702 [TBL] [Abstract][Full Text] [Related]
34. Tim-4 functions as a scavenger receptor for phagocytosis of exogenous particles. Min C; Park J; Kim G; Moon H; Lee SA; Kim D; Moon B; Yang S; Lee J; Kim K; Cho H; Park J; Lee DH; Lee G; Park D Cell Death Dis; 2020 Jul; 11(7):561. PubMed ID: 32703939 [TBL] [Abstract][Full Text] [Related]
35. Tolerogenic Nano-/Microparticle Vaccines for Immunotherapy. Liu Q; Chen G; Liu X; Tao L; Fan Y; Xia T ACS Nano; 2024 Feb; ():. PubMed ID: 38323542 [TBL] [Abstract][Full Text] [Related]
36. Antibody targeting of phosphatidylserine for the detection and immunotherapy of cancer. Belzile O; Huang X; Gong J; Carlson J; Schroit AJ; Brekken RA; Freimark BD Immunotargets Ther; 2018; 7():1-14. PubMed ID: 29417044 [TBL] [Abstract][Full Text] [Related]
37. Tolerance strategies employing antigen-coupled apoptotic cells and carboxylated PLG nanoparticles for the treatment of type 1 diabetes. Prasad S; Xu D; Miller SD Rev Diabet Stud; 2012; 9(4):319-27. PubMed ID: 23804269 [TBL] [Abstract][Full Text] [Related]
38. Loss of phospholipid asymmetry and surface exposure of phosphatidylserine is required for phagocytosis of apoptotic cells by macrophages and fibroblasts. Fadok VA; de Cathelineau A ; Daleke DL; Henson PM; Bratton DL J Biol Chem; 2001 Jan; 276(2):1071-7. PubMed ID: 10986279 [TBL] [Abstract][Full Text] [Related]
39. Involvement of splenic marginal zone macrophages in the recognition of systemically administered phosphatidylserine-coated liposomes in mice. Tada R; Nagao K; Tanaka R; Yamada S; Watanabe A; Negishi Y Int Immunopharmacol; 2022 Nov; 112():109209. PubMed ID: 36084540 [TBL] [Abstract][Full Text] [Related]
40. C1q binds phosphatidylserine and likely acts as a multiligand-bridging molecule in apoptotic cell recognition. Païdassi H; Tacnet-Delorme P; Garlatti V; Darnault C; Ghebrehiwet B; Gaboriaud C; Arlaud GJ; Frachet P J Immunol; 2008 Feb; 180(4):2329-38. PubMed ID: 18250442 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]